iSAM Funds UK Ltd Sells 6,348 Shares of Genpact Limited (NYSE:G)

iSAM Funds UK Ltd reduced its stake in shares of Genpact Limited (NYSE:G - Free Report) by 55.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,056 shares of the business services provider's stock after selling 6,348 shares during the quarter. iSAM Funds UK Ltd's holdings in Genpact were worth $217,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. HB Wealth Management LLC boosted its stake in Genpact by 18.9% in the fourth quarter. HB Wealth Management LLC now owns 10,224 shares of the business services provider's stock valued at $439,000 after acquiring an additional 1,627 shares during the last quarter. UMB Bank n.a. boosted its stake in Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after acquiring an additional 433 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its stake in Genpact by 22.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider's stock valued at $145,000 after acquiring an additional 619 shares during the last quarter. Phillips Wealth Planners LLC bought a new position in Genpact in the fourth quarter valued at approximately $201,000. Finally, SG Americas Securities LLC bought a new position in Genpact in the fourth quarter valued at approximately $238,000. 96.03% of the stock is owned by institutional investors.

Insider Transactions at Genpact

In related news, Director Nicholas C. Gangestad bought 2,000 shares of Genpact stock in a transaction that occurred on Tuesday, May 13th. The stock was acquired at an average price of $43.97 per share, with a total value of $87,940.00. Following the acquisition, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This represents a 4.20% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is owned by company insiders.

Genpact Stock Up 1.0%

G stock traded up $0.45 during midday trading on Tuesday, hitting $43.96. The company's stock had a trading volume of 217,755 shares, compared to its average volume of 1,571,965. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76. The company's fifty day moving average price is $47.26 and its 200 day moving average price is $47.38. The stock has a market capitalization of $7.69 billion, a P/E ratio of 15.47, a PEG ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. Genpact's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 EPS. As a group, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Needham & Company LLC reduced their price objective on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Mizuho lifted their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, Robert W. Baird cut their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $50.71.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.